tiprankstipranks
Advertisement
Advertisement

DE:2DT Stock Latest News

Amneal Pharmaceuticals resumed with an Overweight at JPMorgan
The FlyAmneal Pharmaceuticals resumed with an Overweight at JPMorgan
4d ago
AMRX
Amneal Pharmaceuticals Completes Kashiv BioSciences Acquisition Financing
PremiumCompany Announcements
Amneal Pharmaceuticals Completes Kashiv BioSciences Acquisition Financing
19d ago
8K
AMRX
Amneal Pharmaceuticals price target raised to $25 from $23 at UBS
PremiumThe Fly
Amneal Pharmaceuticals price target raised to $25 from $23 at UBS
26d ago
AMRX
Amneal Pharmaceuticals Reprices Term Loans to Reduce Interest
PremiumCompany Announcements
Amneal Pharmaceuticals Reprices Term Loans to Reduce Interest
26d ago
8K
AMRX
Amneal Pharmaceuticals price target raised to $25 from $23 at UBS
PremiumThe Fly
Amneal Pharmaceuticals price target raised to $25 from $23 at UBS
27d ago
AMRX
Amneal Pharmaceuticals price target raised to $25 from $23 at UBS
PremiumThe FlyAmneal Pharmaceuticals price target raised to $25 from $23 at UBS
27d ago
AMRX
Amneal Pharmaceuticals’ Earnings Call Signals Strong Growth
Premium
Company Announcements
Amneal Pharmaceuticals’ Earnings Call Signals Strong Growth
28d ago
AMRX
Amneal Stockholders Approve Kashiv BioSciences Acquisition Plans
Premium
Company Announcements
Amneal Stockholders Approve Kashiv BioSciences Acquisition Plans
29d ago
8K
AMRX
Amneal Pharmaceuticals price target raised to $21 from $19 at Goldman Sachs
PremiumThe Fly
Amneal Pharmaceuticals price target raised to $21 from $19 at Goldman Sachs
30d ago
AMRX
Amneal Raises 2026 Outlook After Strong Q2 Results
PremiumCompany Announcements
Amneal Raises 2026 Outlook After Strong Q2 Results
1M ago
8K
AMRX
Amneal Pharmaceuticals reports Q2 adjusted EPS 30c, consensus 23c
PremiumThe Fly
Amneal Pharmaceuticals reports Q2 adjusted EPS 30c, consensus 23c
1M ago
AMRX
Amneal Pharmaceuticals raises 2026 adj EPS view to 96c-$1.06 from 95c-$1.05
PremiumThe Fly
Amneal Pharmaceuticals raises 2026 adj EPS view to 96c-$1.06 from 95c-$1.05
1M ago
AMRX
Amneal receives FDA approval for additional iohexol strengths, presentations
PremiumThe FlyAmneal receives FDA approval for additional iohexol strengths, presentations
1M ago
AMRX
Amneal Pharmaceuticals price target raised to $23 from $19 at UBS
Premium
The Fly
Amneal Pharmaceuticals price target raised to $23 from $19 at UBS
2M ago
AMRX
FDA selects seven participants for PreCheck Pilot Program
Premium
The Fly
FDA selects seven participants for PreCheck Pilot Program
2M ago
LLY
AMRX
Eli Lilly, Regeneron among first selections for FDA PreCheck program, CNBC says
PremiumThe Fly
Eli Lilly, Regeneron among first selections for FDA PreCheck program, CNBC says
2M ago
LLY
AMRX
Zambon, Amneal Pharmaceuticals announce CHMP opinion recommending Hopledo
PremiumThe Fly
Zambon, Amneal Pharmaceuticals announce CHMP opinion recommending Hopledo
2M ago
AMRX
Amneal Pharmaceuticals announces interim results from ELEVATE-PD study
PremiumThe Fly
Amneal Pharmaceuticals announces interim results from ELEVATE-PD study
3M ago
AMRX
Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution
PremiumThe Fly
Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution
3M ago
AMRX
Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution
PremiumThe FlyAmneal Pharmaceuticals announces FDA approval of romidepsin injection solution
3M ago
AMRX
Amneal Pharmaceuticals price target raised to $16 from $15 at Barclays
Premium
The Fly
Amneal Pharmaceuticals price target raised to $16 from $15 at Barclays
3M ago
AMRX
Amneal Pharma Bets Big on Biosimilars in Q1 Call
Premium
Company Announcements
Amneal Pharma Bets Big on Biosimilars in Q1 Call
3M ago
AMRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >